Skip to content

PPBT

Purple Biotech Ltd.

NASDAQ · Healthcare · Biotechnology · IL

$1.08
−5.26%
Ask drillr

Year over year

Reported trailing growth

Revenue
—
EBITDA
—
EBIT
—
EPS
+72.3%
Free cash flow
+12.1%
Operating cash flow
+12.2%

Forward estimates

Based on analyst estimates

Revenue
—
EBITDA
—
EPS
-35.1%

Three-year CAGR

Revenue
—
EBITDA
—
EBIT
—
Net income
—
EPS
-24.4%
Free cash flow
+61.4%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026